117,205 Shares in Cardinal Health, Inc. (NYSE:CAH) Purchased by CWA Asset Management Group LLC

CWA Asset Management Group LLC bought a new position in Cardinal Health, Inc. (NYSE:CAH - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 117,205 shares of the company's stock, valued at approximately $12,954,000.

Other hedge funds have also recently modified their holdings of the company. Point72 Asset Management L.P. purchased a new stake in shares of Cardinal Health during the 2nd quarter valued at about $90,440,000. Acadian Asset Management LLC boosted its holdings in Cardinal Health by 19.1% in the first quarter. Acadian Asset Management LLC now owns 3,723,159 shares of the company's stock worth $416,585,000 after purchasing an additional 598,002 shares during the last quarter. Jupiter Asset Management Ltd. bought a new stake in Cardinal Health in the 1st quarter worth approximately $56,454,000. Jacobs Levy Equity Management Inc. raised its stake in Cardinal Health by 265.6% during the 1st quarter. Jacobs Levy Equity Management Inc. now owns 657,526 shares of the company's stock valued at $73,577,000 after buying an additional 477,682 shares during the last quarter. Finally, Swedbank AB bought a new position in shares of Cardinal Health during the 1st quarter valued at $48,673,000. Hedge funds and other institutional investors own 87.17% of the company's stock.

Insider Transactions at Cardinal Health

In other Cardinal Health news, insider Jessica L. Mayer sold 17,896 shares of the firm's stock in a transaction that occurred on Thursday, August 15th. The stock was sold at an average price of $106.48, for a total transaction of $1,905,566.08. Following the completion of the transaction, the insider now owns 94,529 shares in the company, valued at $10,065,447.92. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. In related news, CFO Aaron E. Alt sold 2,323 shares of the stock in a transaction on Monday, August 19th. The stock was sold at an average price of $108.91, for a total transaction of $252,997.93. Following the sale, the chief financial officer now owns 36,867 shares in the company, valued at approximately $4,015,184.97. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Jessica L. Mayer sold 17,896 shares of the stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $106.48, for a total transaction of $1,905,566.08. Following the completion of the sale, the insider now directly owns 94,529 shares in the company, valued at approximately $10,065,447.92. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 113,963 shares of company stock valued at $12,379,980. 0.09% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several brokerages recently commented on CAH. UBS Group lifted their price objective on Cardinal Health from $134.00 to $139.00 and gave the stock a "buy" rating in a report on Monday, November 4th. Robert W. Baird raised their price objective on shares of Cardinal Health from $130.00 to $137.00 and gave the stock an "outperform" rating in a report on Thursday, August 15th. JPMorgan Chase & Co. upped their target price on shares of Cardinal Health from $111.00 to $123.00 and gave the company a "neutral" rating in a report on Wednesday, August 21st. Mizuho increased their price target on shares of Cardinal Health from $110.00 to $120.00 and gave the stock a "neutral" rating in a research report on Monday, November 4th. Finally, Citigroup cut their price objective on shares of Cardinal Health from $115.00 to $107.00 and set a "neutral" rating for the company in a research report on Friday, July 19th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $123.00.

Cardinal Health Trading Up 2.0 %

CAH traded up $2.34 on Friday, hitting $120.56. 2,791,186 shares of the company's stock traded hands, compared to its average volume of 1,900,659. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $121.79. The firm has a market cap of $29.18 billion, a price-to-earnings ratio of 23.46, a P/E/G ratio of 1.44 and a beta of 0.60. The company's 50 day simple moving average is $112.22 and its 200-day simple moving average is $104.54.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings data on Friday, November 1st. The company reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.26. The firm had revenue of $52.28 billion for the quarter, compared to analysts' expectations of $50.90 billion. Cardinal Health had a net margin of 0.56% and a negative return on equity of 56.56%. The company's revenue for the quarter was down 4.3% compared to the same quarter last year. During the same quarter last year, the business posted $1.73 earnings per share. As a group, equities analysts anticipate that Cardinal Health, Inc. will post 7.83 EPS for the current fiscal year.

Cardinal Health Cuts Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be given a dividend of $0.5056 per share. The ex-dividend date of this dividend is Thursday, January 2nd. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.68%. Cardinal Health's payout ratio is 39.30%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.